STERIS PLC

STE stock represents a publicly traded security issued by STERIS plc, a company listed on the New York Stock Exchange. It gives investors a partial ownership interest in the business, which provides sterilization, contamination prevention, and related products and services. STE's business spans healthcare, pharmaceutical, and industrial markets, and its shares trade under the ticker STE. For current details such as price and market value, refer to the latest data shown on this page.

STE operates in the medical devices and life sciences equipment industry, with a focus on sterilization and contamination control. The company serves hospitals, surgical centers, pharmaceutical manufacturers, and research facilities. Its offerings include sterilizers, washers, surgical tables, and consumables, placing it at the intersection of healthcare and industrial safety. This industry exposure means STE is influenced by healthcare spending, hospital capital budgets, and regulatory standards.

The latest price of STE stock is displayed on this page and updates with market activity. Because share prices fluctuate throughout the trading day, the most accurate current quote is the one shown above. Investors often compare the live price to the day's open, previous close, and 52-week range to understand short-term movement. For any decision, rely on the latest available STE data rather than a fixed figure.

The 52-week range for STE stock shows the lowest and highest prices at which shares have traded over the past year. It helps investors gauge where the current price sits relative to its annual high and low. The exact range is provided in the price data section on this page. Reviewing it alongside recent performance can give context about volatility and market sentiment toward STE.

Valuation of STE can be assessed using metrics such as the price-to-earnings ratio, price-to-sales, and enterprise value to EBITDA. These compare STE's share price to its earnings, revenue, or cash flow. Investors also consider growth rates and margins relative to peers. The appropriate metrics depend on whether STE is viewed as a steady compounder or a cyclical equipment maker. Current valuation data appears on this page.

STE faces risks tied to its healthcare and industrial markets, including regulatory changes, product recalls, and competition from other sterilization and surgical equipment providers. Hospital capital spending cycles can affect demand for its larger systems, while supply chain disruptions may impact costs. International operations add currency and geopolitical exposure. Changes in interest rates can also influence borrowing costs and valuation. These factors can contribute to STE stock volatility.